vs

Side-by-side financial comparison of Fulgent Genetics, Inc. (FLGT) and GDEV Inc. (GDEV). Click either name above to swap in a different company.

GDEV Inc. is the larger business by last-quarter revenue ($119.9M vs $71.1M, roughly 1.7× Fulgent Genetics, Inc.). On growth, GDEV Inc. posted the faster year-over-year revenue change (13.3% vs -3.2%).

Fulgent Genetics, Inc. is a molecular diagnostics technology firm that develops and offers genetic testing services including carrier screening, oncology testing, infectious disease detection, and hereditary condition analysis, serving clinical providers, pharma firms, research institutions and public health groups primarily in North America.

GDEV Inc. is a gaming and entertainment holding company. It is a publicly traded company listed on the Nasdaq stock exchange, headquartered in Limassol, Cyprus. The holding was evolved in June 2023 from a video game company Nexters, founded in 2014, one of the top five independent mobile game companies in Europe. Subsidiaries of GDEV include Nexters Studio, which operates offices in Cyprus, Armenia, and Kazakhstan, as well as Cubic Games, Royal Ark, Game Gears and Light Hour Games. The compan...

FLGT vs GDEV — Head-to-Head

Bigger by revenue
GDEV
GDEV
1.7× larger
GDEV
$119.9M
$71.1M
FLGT
Growing faster (revenue YoY)
GDEV
GDEV
+16.5% gap
GDEV
13.3%
-3.2%
FLGT

Income Statement — Q1 FY2026 vs Q2 FY2025

Metric
FLGT
FLGT
GDEV
GDEV
Revenue
$71.1M
$119.9M
Net Profit
$16.6M
Gross Margin
30.2%
Operating Margin
21.1%
15.5%
Net Margin
13.9%
Revenue YoY
-3.2%
13.3%
Net Profit YoY
13.0%
EPS (diluted)
$0.04
$0.90

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FLGT
FLGT
GDEV
GDEV
Q1 26
$71.1M
Q4 25
$83.3M
Q3 25
$84.1M
Q2 25
$81.8M
$119.9M
Q1 25
$73.5M
Q4 24
$76.2M
Q3 24
$71.7M
Q2 24
$71.0M
$105.8M
Net Profit
FLGT
FLGT
GDEV
GDEV
Q1 26
Q4 25
$-23.4M
Q3 25
$-6.6M
Q2 25
$-19.0M
$16.6M
Q1 25
$-11.5M
Q4 24
$-5.9M
Q3 24
$-14.6M
Q2 24
$-8.7M
$14.7M
Gross Margin
FLGT
FLGT
GDEV
GDEV
Q1 26
30.2%
Q4 25
39.1%
Q3 25
42.2%
Q2 25
42.1%
Q1 25
38.6%
Q4 24
41.8%
Q3 24
37.3%
Q2 24
37.3%
Operating Margin
FLGT
FLGT
GDEV
GDEV
Q1 26
21.1%
Q4 25
-43.5%
Q3 25
-18.3%
Q2 25
-24.1%
15.5%
Q1 25
-26.9%
Q4 24
-21.2%
Q3 24
-23.8%
Q2 24
-26.6%
14.4%
Net Margin
FLGT
FLGT
GDEV
GDEV
Q1 26
Q4 25
-28.1%
Q3 25
-7.9%
Q2 25
-23.2%
13.9%
Q1 25
-15.7%
Q4 24
-7.7%
Q3 24
-20.4%
Q2 24
-12.3%
13.9%
EPS (diluted)
FLGT
FLGT
GDEV
GDEV
Q1 26
$0.04
Q4 25
Q3 25
Q2 25
$0.90
Q1 25
Q4 24
Q3 24
Q2 24
$0.81

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FLGT
FLGT
GDEV
GDEV
Cash + ST InvestmentsLiquidity on hand
$23.4M
$41.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$-129.4M
Total Assets
$1.2B
$210.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FLGT
FLGT
GDEV
GDEV
Q1 26
$23.4M
Q4 25
$50.2M
Q3 25
$117.6M
Q2 25
$87.9M
$41.6M
Q1 25
$67.3M
Q4 24
$55.1M
Q3 24
$58.0M
Q2 24
$65.1M
$50.8M
Stockholders' Equity
FLGT
FLGT
GDEV
GDEV
Q1 26
Q4 25
$1.1B
Q3 25
$1.1B
Q2 25
$1.1B
$-129.4M
Q1 25
$1.1B
Q4 24
$1.1B
Q3 24
$1.1B
Q2 24
$1.1B
$-118.7M
Total Assets
FLGT
FLGT
GDEV
GDEV
Q1 26
$1.2B
Q4 25
$1.2B
Q3 25
$1.2B
Q2 25
$1.2B
$210.2M
Q1 25
$1.2B
Q4 24
$1.2B
Q3 24
$1.2B
Q2 24
$1.2B
$282.8M

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons